Seelos Therapeutics Inc (SEEL)
1.11
+0.08
(+7.77%)
USD |
OTCM |
Nov 04, 12:34
Seelos Therapeutics Max Drawdown (5Y): 100.00% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 100.00% |
| September 30, 2024 | 99.99% |
| August 31, 2024 | 99.98% |
| July 31, 2024 | 99.97% |
| June 30, 2024 | 99.96% |
| May 31, 2024 | 99.96% |
| April 30, 2024 | 99.96% |
| March 31, 2024 | 99.96% |
| February 29, 2024 | 99.96% |
| January 31, 2024 | 99.96% |
| December 31, 2023 | 99.96% |
| November 30, 2023 | 99.96% |
| October 31, 2023 | 99.93% |
| September 30, 2023 | 99.93% |
| August 31, 2023 | 99.93% |
| July 31, 2023 | 99.93% |
| June 30, 2023 | 99.93% |
| May 31, 2023 | 99.93% |
| April 30, 2023 | 99.93% |
| March 31, 2023 | 99.93% |
| February 28, 2023 | 99.93% |
| January 31, 2023 | 99.93% |
| December 31, 2022 | 99.93% |
| November 30, 2022 | 99.93% |
| October 31, 2022 | 99.93% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.93% |
| August 31, 2022 | 99.93% |
| July 31, 2022 | 99.93% |
| June 30, 2022 | 99.93% |
| May 31, 2022 | 99.93% |
| April 30, 2022 | 99.93% |
| March 31, 2022 | 99.93% |
| February 28, 2022 | 99.93% |
| January 31, 2022 | 99.93% |
| December 31, 2021 | 99.93% |
| November 30, 2021 | 99.93% |
| October 31, 2021 | 99.93% |
| September 30, 2021 | 99.93% |
| August 31, 2021 | 99.93% |
| July 31, 2021 | 99.93% |
| June 30, 2021 | 99.93% |
| May 31, 2021 | 99.93% |
| April 30, 2021 | 99.93% |
| March 31, 2021 | 99.93% |
| February 28, 2021 | 99.93% |
| January 31, 2021 | 99.93% |
| December 31, 2020 | 99.93% |
| November 30, 2020 | 99.93% |
| October 31, 2020 | 99.93% |
| September 30, 2020 | 99.93% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.91%
Minimum
Nov 2019
100.00%
Maximum
Oct 2024
99.93%
Average
99.93%
Median
Apr 2020
Max Drawdown (5Y) Benchmarks
| 180 Life Sciences Corp | 99.97% |
| Cassava Sciences Inc | 92.93% |
| Cara Therapeutics Inc | 99.17% |
| Citius Pharmaceuticals Inc | 98.79% |
| Moleculin Biotech Inc | 98.34% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -107.78 |
| Beta (5Y) | 1.944 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 214.9% |
| Historical Sharpe Ratio (5Y) | -0.3847 |
| Historical Sortino (5Y) | -1.208 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 58.74% |